Kazmierczak Steven C, Morosyuk Svetlana, Rajkumar Rahul
Department of Pathology, Oregon Health & Science University, Portland, OR, USA.
Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
J Appl Lab Med. 2022 May 4;7(3):650-660. doi: 10.1093/jalm/jfab158.
Preanalytical errors due to poor sample quality or improper sample handling may occur with point-of-care testing (POCT).
A retrospective analysis was conducted using deidentified records for 15 479 i-STAT® cartridges run at the Oregon Health & Science University Emergency Department (ED) between December 2015 and August 2016. Data were collected from electronic health records and device middleware for CG4+, CHEM8+, and Troponin cartridges. The frequency of POCT errors was evaluated by cartridge type. The effect of user experience on error frequency, impact of error on hospital length of stay (LOS), and test turnaround time (TAT) were all evaluated. Direct costs incurred due to Chem8+ and Troponin cartridge waste and indirect costs as avoidable nursing staff labor were estimated over 2 years.
A total of 935 erroneous results were identified (6.0% of all cartridges). Three hundred seventy-two (2.4%) were unusable results, and 563 (3.6%) were cartridge errors, of which 163 were classified by device error codes as poor sample quality/improper sample handling. Error rates were inversely correlated with user experience based on number of tests performed during the 9-month period. Compared to nonerroneous results, test TATs and LOS were significantly longer with erroneous results (P < 0.01). Over 2 years, direct costs incurred due to cartridge waste was $45 000, and indirect cost was estimated between 486 and 729 h in avoidable nursing labor.
Preanalytical POCT errors were inversely correlated with user experience and significantly impacted clinical productivity in the ED based on LOS and test TAT.
即时检验(POCT)可能会因样本质量差或样本处理不当而出现分析前误差。
采用回顾性分析方法,使用俄勒冈健康与科学大学急诊科在2015年12月至2016年8月期间运行的15479个i-STAT®检测卡的去识别记录。从电子健康记录和设备中间件收集CG4 +、CHEM8 +和肌钙蛋白检测卡的数据。按检测卡类型评估POCT误差的频率。评估了用户经验对误差频率的影响、误差对住院时间(LOS)的影响以及检测周转时间(TAT)。估计了2年内因Chem8 +和肌钙蛋白检测卡浪费产生的直接成本以及作为可避免护理人员劳动的间接成本。
共识别出935个错误结果(占所有检测卡的6.0%)。372个(2.4%)为不可用结果,563个(3.6%)为检测卡误差,其中163个根据设备错误代码分类为样本质量差/样本处理不当。基于9个月期间进行的检测数量,误差率与用户经验呈负相关。与无错误结果相比,错误结果的检测TAT和LOS显著更长(P < 0.01)。2年多来,因检测卡浪费产生的直接成本为45000美元,间接成本估计为可避免护理劳动的486至729小时。
分析前POCT误差与用户经验呈负相关,并基于LOS和检测TAT显著影响急诊科的临床生产力。